DNAPrint Genomics Inc. Annual stock financials by MarketWatch. View the latest DNAG financial statements, income statements and financial ratios.

DNAPrint genomics Inc. said it would acquire some of the assets of Ellipsis Biotherapeutics Corp. in a stock deal valued at about $112,000. Ellipsis will sell its clinical genomics and genotyping ...

DNAPrint™ genomics, Inc. has announced that it has established DNAPrint Pharmaceuticals, Inc., a wholly owned pharmaceutical subsidiary focused on personalized medicine. “Since its inception, DNAPrint ...

SARASOTA, Fla., June 22, 2006 (PRIMEZONE) -- DNAPrint Genomics, Inc. (OTCBB:DNAG) President and Chief Executive Officer Richard Gabriel told shareholders at the Annual Meeting today that the ...

DNAPrint Genomics, Inc. has announced the expansion of the Company’s high-throughput genotyping capacity from 1.3 million to 3.9 million genotypes per day. "Multiplexing and advanced automation ...

DNAPrint genomics Inc. in Sarasota announced Wednesday that it has secured a commitment from La Jolla Cove Investors Inc. to invest up to $8 million in the company over approximately the next two ...

SARASOTA -- DNAPrint Genomics posted a loss of $906,292 during the first quarter as it continued efforts to milk profits out of its genetic testing products. The per-share measure of the loss is so ...

SARASOTA -- DNAPrint Genomics Inc. continued its financial losing streak in 2002, finishing the year $3.11 million in the red. That's compared with a $2.59 million loss in 2001. Since December 1998, ...

DNAPrint Genomics Inc. DNAPrint Genomics, Inc. engages in the research and development of genomics-based products and services for biomedical and forensics. The company was founded by Tony N. Frudakis ...

Find the latest DNAPrint Genomics, Inc. (DNAG) stock quote, history, news and other vital information to help you with your stock trading and investing.